Fast forward to the first quarter of 2026, and Intel has returned to meaningful growth -- even in a supply constrained ...

The SpaceX IPO is attracting a lot of attention, but one of its competitors is a better buy. SpaceX filed confidentially to ...

Teva Pharmaceutical Industries ( TEVA +2.02%) will unveil its first-quarter results this Wednesday, April 29. Many Teva ...

If Novo Nordisk's initiatives work and the company can cut the cost and time to develop drugs by even 5%, that could have a ...

The telecom giant's latest results highlighted impressive growth and strong guidance, further securing its robust dividend.

After falling into bear market territory, Nvidia stock has come roaring back, climbing to a new all-time high. The ongoing ...

This is high-growth investing at its boldest. Powered by David Gardner's proven framework for identifying industry-changing ...

Some stocks saw massive surges during the early pandemic years because their businesses were well-positioned to perform well ...

The company boasts a low cash payout ratio of just 42.3%, given it plenty of room for more payout increases. Gilead Sciences ...

Three sectors that could be the most at risk for share-price disruption are cybersecurity, banking, and cryptocurrency stocks. And among these sectors, a handful of companies could potentially feel ...

Eli Lilly is best known for its work in the weight loss market. The company has billion-dollar drugs in other areas. The ...

It hasn't held up, actually, although retirees depending on Social Security aren't necessarily powerless to do something ...